SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-κB activation early during virus infection. We also identify that the SARS-CoV-2 viral proteins NSP1 and NSP13 can block interferon activation via distinct mechanisms. NSP1 antagonizes interferon signaling by suppressing host mRNA translation, while NSP13 downregulates interferon and NF-κB promoter signaling by limiting TBK1 and IRF3 activation, as phospho-TBK1 and phospho-IRF3 protein levels are reduced with increasing levels of NSP13 protein expression. NSP13 can also reduce NF-κB activation by both limiting NF-κB phosphorylation and nuclear translocation. Last, we also show that NSP13 binds to TBK1 and downregulates IFIT1 protein expression. Collectively, these data illustrate that SARS-CoV-2 bypasses multiple innate immune activation pathways through distinct mechanisms.

[1]  Z. Rao,et al.  Architecture of a SARS-CoV-2 mini replication and transcription complex , 2020, Nature Communications.

[2]  M. White,et al.  Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase , 2020, The journal of physical chemistry letters.

[3]  M. Guttman,et al.  SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses , 2020, Cell.

[4]  Vineet D. Menachery,et al.  Evasion of Type I Interferon by SARS-CoV-2 , 2020, Cell Reports.

[5]  L. Ren,et al.  Activation and evasion of type I interferon responses by SARS-CoV-2 , 2020, Nature Communications.

[6]  B. Chait,et al.  Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex , 2020, Cell.

[7]  Jian-Piao Cai,et al.  Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer , 2020, Journal of Infection.

[8]  N. Ban,et al.  SARS-CoV-2 Nsp1 binds ribosomal mRNA channel to inhibit translation , 2020, bioRxiv.

[9]  Rui Luo,et al.  The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway , 2020, Virus Research.

[10]  Thomas Becker,et al.  Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 , 2020, Science.

[11]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[12]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[13]  P. Horby,et al.  A novel coronavirus outbreak of global health concern , 2020, The Lancet.

[14]  H. Liu,et al.  The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent Immune Responses , 2019, Front. Immunol..

[15]  W. Kamitani,et al.  MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA , 2017, Virology.

[16]  D. Baltimore,et al.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology , 2017, Cell.

[17]  I. Sola,et al.  Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses , 2016, PLoS pathogens.

[18]  J. Casanova,et al.  Human TBK1: A Gatekeeper of Neuroinflammation. , 2016, Trends in molecular medicine.

[19]  D. Scadden,et al.  Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway , 2016, Proceedings of the National Academy of Sciences.

[20]  Wenjie Tan,et al.  Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets , 2015, Scientific Reports.

[21]  Krishna Shankara Narayanan,et al.  Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin , 2015, Journal of Virology.

[22]  Krystal L. Matthews,et al.  The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. , 2014, The Journal of general virology.

[23]  K. Yuen,et al.  Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response , 2014, Journal of Virology.

[24]  K. Kok,et al.  Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain , 2014, Cellular and Molecular Immunology.

[25]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[26]  W. Kamitani,et al.  Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA , 2012, Journal of Virology.

[27]  Krishna Shankara Narayanan,et al.  Severe Acute Respiratory Syndrome Coronavirus Protein nsp1 Is a Novel Eukaryotic Translation Inhibitor That Represses Multiple Steps of Translation Initiation , 2012, Journal of Virology.

[28]  G. Superti-Furga,et al.  Functional Dissection of the TBK1 Molecular Network , 2011, PloS one.

[29]  M. Gale,et al.  Immune signaling by RIG-I-like receptors. , 2011, Immunity.

[30]  Shinji Makino,et al.  A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein , 2009, Nature Structural &Molecular Biology.

[31]  Dong-Yan Jin,et al.  Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ Complex* , 2009, The Journal of Biological Chemistry.

[32]  Krishna Shankara Narayanan,et al.  Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells , 2008, Journal of Virology.

[33]  Krishna Shankara Narayanan,et al.  Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation , 2006, Proceedings of the National Academy of Sciences.

[34]  S. Lemon,et al.  Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.

[35]  Andreas Pichlmair,et al.  Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.

[36]  Eric J. Snijder,et al.  Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase , 2004, Journal of Virology.

[37]  J. Peiris,et al.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 , 2003, The Lancet.

[38]  T. Maniatis,et al.  IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.

[39]  D. Aaronson,et al.  A Road Map for Those Who Don't Know JAK-STAT , 2002, Science.

[40]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.

[41]  J. Hiscott,et al.  Triggering the interferon response: the role of IRF-3 transcription factor. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.